| |
|
 |
|
|
|
|
| |
Mon 26 Nov 2007
- Tue 27 Nov 2007
Crowne Plaza London City, London, United Kingdom
|
|
|
|
Industry challenges
As the big quality, cost, innovation conundrum continues, the situation in the UK becomes more frustrating than ever. Despite innovation being the key to the industry’s growth and prosperity, the major issue remains one of funding and the problem of the purchaser’s focus on price rather than value for money. Thus, the key question on the tip of every manufacturer’s tongue is:
How do I successfully get my product into the NHS?
Trying to introduce your product into the UK market requires:
- Excellent navigation of the UK framework, including the multiple routes to entry
- Balancing the demands of government regulations with organisational and patient needs
- Containing production costs, in an effort to produce the most reliable and safest medical devices for your patients
In addition, it is essential to create a dialogue with key decision makers, voice your opinion and stay on top of changes that will impact the introduction of your innovation into the market.
Join us to tackle the key issues and discuss:
Informa’s annual conference on ‘Innovation and Procurement in the UK medical device market’ presents key changes and assesses the impact of these developments for the UK medical device industry.
This event provides Medical Device manufacturers (Large, small & SME's) an A-Z roadmap of how to take an innovation through from concept to market.
With a combination of expert NHS and industry presentations, you will be delivered up-to–the–minute practical guidance:
- Evaluate NHS plans to improve the UK healthcare framework and understand the implications of these changes on the medical device industry
- Assess the challenges to innovation from an NHS perspective and understand how they evaluate your technologies
- Hear case study presentations of how manufacturers have tackled the challenges of getting a new innovation into the NHS
- Explore the opportunity to link commissioning for quality with ensuring that ‘quality enhancing’ innovations are adopted
- Understand how is procurement organized in the UK and develop Techniques to strategically maintain value in the market
- Gain a deeper understanding of HRG Version 4, Payment by Results and the Collaborative Procurement Hubs
|
Don't Miss
28th November 2007:
Post conference workshop 1:
Improving the uptake of innovative products from SME’s
Led by: Dr Mike Hudson, Managing Director, Sultan Scientific Ltd
Post conference workshop 2:
Valuing medical device technology
|
|
Key Presentations
- Chan Wheeler, Commercial Director General, Department of Health, UK
- Sandra Lawrence, Government Affairs and Reimbursement Manager, Stryker UK
- Philip Salt, Chief Executive, Salts Healthcare
- Patrick Chaney, Managing Director, Disposable Medical Instruments
- Joe Rafferty, Director of Commissioning and Performance, NHS Northwest
- Maire Smith, Director of Technology and Product Innovation, National Innovation Centre, UK
- Philip Needham, Managing Director, Cardionetics Limited
- Professor Hugh Pennington, Aberdeen University, UK
- Brian Winn, Head of Technology and Product Introduction, National Innovation Centre, UK
- David Marks, Partner, CMS Cameron McKenna LLP
- Joshua Rowe, Managing Director, Broomwell Healthwatch, UK
- Nick Manson, NHS Institute for Innovation and Improvement, University of Warwick Campus, UK
|